A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Cysteamine
Levocabastine
The risk or severity of QTc prolongation can be increased when Levocabastine is combined with Clomipramine.
Cysteamine
Ketotifen
The risk or severity of QTc prolongation can be increased when Ketotifen is combined with Clomipramine.
Cysteamine
Emedastine
The risk or severity of QTc prolongation can be increased when Emedastine is combined with Clomipramine.
Cysteamine
Telavancin
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Telavancin.
Cysteamine
Dexverapamil
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Dexverapamil.
Cysteamine
Otilonium
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Otilonium.
Cysteamine
Eperisone
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Eperisone.
Cysteamine
Fendiline
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Fendiline.
Cysteamine
Bedaquiline
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Bedaquiline.
Cysteamine
Prenylamine
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Prenylamine.
Cysteamine
Levacetylmethadol
The risk or severity of QTc prolongation can be increased when Levacetylmethadol is combined with Clomipramine.
Cysteamine
Granisetron
The risk or severity of QTc prolongation can be increased when Granisetron is combined with Clomipramine.
Cysteamine
Lorcainide
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Lorcainide.
Cysteamine
Bunaftine
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Bunaftine.
Cysteamine
Nizofenone
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Nizofenone.
Cysteamine
Oxatomide
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Oxatomide.
Cysteamine
Abexinostat
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Abexinostat.
Cysteamine
Ricolinostat
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Ricolinostat.
Cysteamine
Simendan
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with Simendan.
Cysteamine
CUDC-101
The risk or severity of QTc prolongation can be increased when Clomipramine is combined with CUDC-101.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3